| Michael Alexander Diiorio, MD | |
|
60 Fenwood Rd, Boston, MA 02115-6128 | |
| (617) 732-5500 | |
| Not Available |
| Full Name | Michael Alexander Diiorio |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 60 Fenwood Rd, Boston, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598224859 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Alexander Diiorio, MD 60 Fenwood Rd, Boston, MA 02115-6128 Ph: (908) 922-1651 | Michael Alexander Diiorio, MD 60 Fenwood Rd, Boston, MA 02115-6128 Ph: (617) 732-5500 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that new analyses of data were presented from its clinical program and pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the Phase 3 studies that evaluated XIAFLEX® (collagenase clostridium histolyticum or CCH) for the treatment of Peyronie's disease (PD).
The city of London has launched an innovative service, funded by ESA, which delivers air pollution alerts and health advice via SMS text messages to those who suffer from asthma and other conditions vulnerable to poor air quality.
Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced financial results for the quarter ended March 31, 2010, provided an update on progress towards achievement of 2010 goals as well as 2010 financial guidance.
Five minority fellowship program grants are being awarded by the Substance Abuse and Mental Health Services Administration for a total of up to $12.2 million. These three-year grants will be used to train a new wave of behavioral health care providers. The program focuses on increasing the number of culturally competent behavioral health professionals available in underserved racially and ethnically diverse communities.
› Verified 9 days ago